These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 19202450)
1. Prophylaxis with caspofungin for invasive fungal infections in high-risk liver transplant recipients. Fortún J; Martín-Dávila P; Montejo M; Muñoz P; Cisneros JM; Ramos A; Aragón C; Blanes M; San Juan R; Gavaldá J; Llinares P; Transplantation; 2009 Feb; 87(3):424-35. PubMed ID: 19202450 [TBL] [Abstract][Full Text] [Related]
2. Prospective interventional study to evaluate the efficacy and safety of liposomal amphotericin B as prophylaxis of fungal infections in high-risk liver transplant recipients. Castroagudín JF; Pontón C; Bustamante M; Otero E; Martínez J; Tomé S; Conde R; Segade FR; Delgado M; Brage A; Galbán C; Varo E Transplant Proc; 2005 Nov; 37(9):3965-7. PubMed ID: 16386598 [TBL] [Abstract][Full Text] [Related]
3. Evaluating prophylaxis of invasive fungal infections in patients with haematologic malignancies. Maertens J Eur J Haematol; 2007 Apr; 78(4):275-82. PubMed ID: 17241370 [TBL] [Abstract][Full Text] [Related]
4. [Invasive fungal infections in liver transplant recipients: analysis of 21 cases]. Miguélez M; Lumbreras C; Herrero JA; Aguado JM; del Palacio A; Colina F; Gómez R; Lizasoain M; Moreno E; Rodríguez-Noriega A Med Clin (Barc); 1998 Mar; 110(11):406-10. PubMed ID: 9608495 [TBL] [Abstract][Full Text] [Related]
5. Targeted prophylaxis with amphotericin B lipid complex in liver transplantation. Singhal S; Ellis RW; Jones SG; Miller SJ; Fisher NC; Hastings JG; Mutimer DJ Liver Transpl; 2000 Sep; 6(5):588-95. PubMed ID: 10980058 [TBL] [Abstract][Full Text] [Related]
6. Prevention of invasive fungal infections in liver transplant recipients: the role of prophylaxis with lipid formulations of amphotericin B in high-risk patients. Fortún J; Martín-Davila P; Moreno S; Barcena R; de Vicente E; Honrubia A; García M; Nuño J; Candela A; Uriarte M; Pintado V J Antimicrob Chemother; 2003 Nov; 52(5):813-9. PubMed ID: 14563893 [TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of itraconazole prophylaxis for fungal infections after orthotopic liver transplantation: a prospective, randomized, double-blind study. Sharpe MD; Ghent C; Grant D; Horbay GL; McDougal J; David Colby W Transplantation; 2003 Sep; 76(6):977-83. PubMed ID: 14508365 [TBL] [Abstract][Full Text] [Related]
8. Changes in the spectrum and risk factors for invasive candidiasis in liver transplant recipients: prospective, multicenter, case-controlled study. Husain S; Tollemar J; Dominguez EA; Baumgarten K; Humar A; Paterson DL; Wagener MM; Kusne S; Singh N Transplantation; 2003 Jun; 75(12):2023-9. PubMed ID: 12829905 [TBL] [Abstract][Full Text] [Related]
9. Universal prophylaxis with fluconazole for the prevention of early invasive fungal infection in low-risk liver transplant recipients. San-Juan R; Aguado JM; Lumbreras C; Fortun J; Len O; Muñoz P; Montejo M; Moreno A; Cordero E; Blanes M; Ramos A; de la Torre-Cisneros J; Lopez-Medrano F; Carratala J; Moreno E; Transplantation; 2011 Aug; 92(3):346-50. PubMed ID: 21709604 [TBL] [Abstract][Full Text] [Related]
11. Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry. Neofytos D; Horn D; Anaissie E; Steinbach W; Olyaei A; Fishman J; Pfaller M; Chang C; Webster K; Marr K Clin Infect Dis; 2009 Feb; 48(3):265-73. PubMed ID: 19115967 [TBL] [Abstract][Full Text] [Related]
12. Invasive fungal infections in liver transplantation. Liu X; Ling Z; Li L; Ruan B Int J Infect Dis; 2011 May; 15(5):e298-304. PubMed ID: 21345708 [TBL] [Abstract][Full Text] [Related]
13. Safety of anidulafungin in solid organ transplant recipients. Aguado JM; Varo E; Usetti P; Pozo JC; Moreno A; Catalán M; Len O; Blanes M; Solé A; Muñoz P; Montejo M; Liver Transpl; 2012 Jun; 18(6):680-5. PubMed ID: 22328277 [TBL] [Abstract][Full Text] [Related]
14. A retrospective analysis of the use of caspofungin in recipients of liver transplant with a modified high index of suspicion for fungal infection. A critical review of mortality, acute cellular rejection, infections, and changes in the liver function tests while on caspofungin. Doria C; Bodzin AS; Vaccino S; Daskalakis C; Krawitz S; Ramirez CB Clin Transplant; 2011; 25(4):569-75. PubMed ID: 20662881 [TBL] [Abstract][Full Text] [Related]
15. Risk stratification and targeted antifungal prophylaxis for prevention of aspergillosis and other invasive mold infections after liver transplantation. Hellinger WC; Bonatti H; Yao JD; Alvarez S; Brumble LM; Keating MR; Mendez JC; Kramer DJ; Dickson RC; Harnois DM; Spivey JR; Hughes CB; Nguyen JH; Steers JL Liver Transpl; 2005 Jun; 11(6):656-62. PubMed ID: 15915482 [TBL] [Abstract][Full Text] [Related]
16. Hematopoietic SCT in patients with a history of invasive fungal infection. Zhang P; Song A; Wang Z; Feng S; Qiu L; Han M Bone Marrow Transplant; 2009 Apr; 43(7):533-7. PubMed ID: 19104496 [TBL] [Abstract][Full Text] [Related]
17. Low-dose amphotericin for prevention of serious fungal infection following liver transplantation. Shah T; Lai WK; Gow P; Leeming J; Mutimer D Transpl Infect Dis; 2005; 7(3-4):126-32. PubMed ID: 16390401 [TBL] [Abstract][Full Text] [Related]